FRZB and urinary bladder neoplasm: Pyrosequencing of the promoter regions of FRZB, KRT13, and HOXB2 was performed in an independent series of 263 bladder tumor patients not examined on the array as well as on 4 non-diseased tumor samples obtained from the NDRI.